A Phase 1 Study of Weekly Everolimus (RAD001) in Combination With Docetaxel in Patients With Metastatic Breast CancerMOULDER, Stacy; GLADISH, Gregory; RIVERA, Edgardo et al.Cancer. 2012, Vol 118, Num 9, pp 2378-2384, issn 0008-543X, 7 p.Article

A 0.8/2.4 GHz Tunable Active Band Pass Filter in InP/Si BiCMOS TechnologyZHIWEI XU; McARDLE-MOORE, Julia; OH, Thomas C et al.IEEE microwave and wireless components letters. 2014, Vol 24, Num 1, pp 47-49, issn 1531-1309, 3 p.Article

Magnetic Resonance Imaging Characteristics of Glioblastoma Multiforme: Implications for Understanding Glioma Ontogeny. CommentariesBOHMAN, Leif-Erik; SWANSON, Kristin R; JAIN, Surbhi et al.Neurosurgery. 2010, Vol 67, Num 5, pp 1319-1328, issn 0148-396X, 10 p.Article

The Ontario Drug Policy Research Network: Bridging the gap between Research and Drug PolicyKHAN, Sobia; MOORE, Julia E; GOMES, Tara et al.Health policy (Amsterdam. Print). 2014, Vol 117, Num 3, pp 392-398, issn 0168-8510, 7 p.Article

Phase I/II Study of Trastuzumab in Combination With Everolimus (RAD001) in Patients With HER2-Overexpressing Metastatic Breast Cancer Who Progressed on Trastuzumab-Based TherapyMORROW, Phuong K; WULF, Gerburg M; KINDELBERGER, David W et al.Journal of clinical oncology. 2011, Vol 29, Num 23, pp 3126-3132, issn 0732-183X, 7 p.Article